JP2005533766A5 - - Google Patents

Download PDF

Info

Publication number
JP2005533766A5
JP2005533766A5 JP2004506794A JP2004506794A JP2005533766A5 JP 2005533766 A5 JP2005533766 A5 JP 2005533766A5 JP 2004506794 A JP2004506794 A JP 2004506794A JP 2004506794 A JP2004506794 A JP 2004506794A JP 2005533766 A5 JP2005533766 A5 JP 2005533766A5
Authority
JP
Japan
Prior art keywords
hydrogen
pharmaceutical composition
tetracycline
cmt
tetracycline compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004506794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/015744 external-priority patent/WO2003099270A1/en
Publication of JP2005533766A publication Critical patent/JP2005533766A/ja
Publication of JP2005533766A5 publication Critical patent/JP2005533766A5/ja
Pending legal-status Critical Current

Links

JP2004506794A 2002-05-20 2003-05-20 アレルギー反応の治療方法 Pending JP2005533766A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38212702P 2002-05-20 2002-05-20
PCT/US2003/015744 WO2003099270A1 (en) 2002-05-20 2003-05-20 Methods of treating allergic reactions

Publications (2)

Publication Number Publication Date
JP2005533766A JP2005533766A (ja) 2005-11-10
JP2005533766A5 true JP2005533766A5 (enExample) 2006-07-06

Family

ID=29584360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004506794A Pending JP2005533766A (ja) 2002-05-20 2003-05-20 アレルギー反応の治療方法

Country Status (7)

Country Link
US (1) US20050164993A1 (enExample)
EP (1) EP1505961A4 (enExample)
JP (1) JP2005533766A (enExample)
KR (1) KR20050007553A (enExample)
AU (1) AU2003245295B2 (enExample)
CA (1) CA2485677C (enExample)
WO (1) WO2003099270A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494944A1 (en) * 2002-08-09 2004-02-19 Helen G. Durkin A method for monitoring the effectiveness of tetracycline in the treatment of asthma
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
EP1684768A4 (en) * 2003-11-06 2007-06-06 Univ New York State Res Found METHOD FOR TREATING ECCEM
WO2006045152A1 (en) * 2004-10-29 2006-05-04 Mayne Pharma International Pty Ltd Improved tabletting process
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
US20140221320A1 (en) * 2011-07-08 2014-08-07 The Research Foundation For The State University Of New York Topical minocycline ointment for suppression of allergic skin responses
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5700816A (en) * 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
US5837696A (en) * 1997-01-15 1998-11-17 The Research Foundation Of State University Of New York Method of inhibiting cancer growth
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
US6946453B2 (en) * 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US6506740B1 (en) * 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US6613756B2 (en) * 2000-05-05 2003-09-02 Wisconsin Alumni Research Foundation Use of tetracycline derivatives in treating multiple sclerosis
US6610274B1 (en) * 2000-12-22 2003-08-26 Wallace J. Gardner Anti-inflammatory composition comprising tetracycline
EP1408987B1 (en) * 2001-07-13 2013-04-10 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
CA2494944A1 (en) * 2002-08-09 2004-02-19 Helen G. Durkin A method for monitoring the effectiveness of tetracycline in the treatment of asthma

Similar Documents

Publication Publication Date Title
JP2005523313A5 (enExample)
CA2485677A1 (en) Methods of treating allergic reactions
JP2004536046A5 (enExample)
AU2002256092C1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
JP2010523684A (ja) テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
AU2002256092A1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
CA2440472A1 (en) Methods of treating acne
JP2010053146A (ja) インターロイキン−10生成を増進するためのテトラサイクリン化合物の使用方法
WO2004078129A2 (en) Method for decreasing low density lipoprotein
JPH10503522A (ja) 化学療法剤とともに使用するための防御性プロスタグランジン
JP2004532828A5 (enExample)
JP2006508128A5 (enExample)
US20080233151A1 (en) Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
RU2005105691A (ru) Пероральное введение кальцитонина
JP2002525299A (ja) 新規白内障形成抑制剤
US20050282786A1 (en) Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
JP2008519848A5 (enExample)
AU2005222937B2 (en) Method for treating aortic stenosis with non-antibacterial tetracycline formulations
WO2026090539A1 (en) Methods of preventing or treating vesicant-induced injury
AU2018303807B2 (en) Treatment of non-inflammatory lesions
WO2024220677A1 (en) Methods for treating and preventing microbial biofilms through the use of glycerol on microbes
HK40126453A (en) Modified release compositions of a gamma-hydroxybutyric acid derivative
JP2007535502A5 (enExample)
HK40087326A (en) Modified release compositions of a gamma-hydroxybutyric acid derivative
WO2007075269A2 (en) Method for inhibiting tooth displacement with non-antibacterial tetracyline formulations